Cargando…
Withaferin A for COVID-19: a Network Pharmacology Approach
COVID-19 has become a global challenge as there are very few treatment options available. This has proved to impact several physiological implications like immunological injury, myocardial infarction, micro-thrombus formation, neurological complications and multi-organ dysfunction. A combination the...
Autores principales: | Mishra, Ashasmita S., Varadarajan, Bhuvaneswari, Sathish, Srayaa, Roy, Sujata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152032/ https://www.ncbi.nlm.nih.gov/pubmed/37129739 http://dx.doi.org/10.1007/s12010-023-04525-7 |
Ejemplares similares
-
Withaferin A: a potential therapeutic agent against COVID-19 infection
por: Straughn, Alex R., et al.
Publicado: (2020) -
Implications of Withaferin A in neurological disorders
por: Ram, Natasha, et al.
Publicado: (2020) -
Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms
por: Xing, Zhichao, et al.
Publicado: (2023) -
Preparation, Characterization, and Pharmacological Investigation of Withaferin-A Loaded Nanosponges for Cancer Therapy; In Vitro, In Vivo and Molecular Docking Studies
por: Shah, Hamid Saeed, et al.
Publicado: (2021) -
Withaferin A Associated Differential Regulation of Inflammatory Cytokines
por: Dubey, Seema, et al.
Publicado: (2018)